1.Women Medical Students and Physicians. 1994 Statistics on Women in U.S. Academic Medicine and Its Implication to Japan.
Medical Education 1996;27(2):77-83
This is an interpretative overview of the newest statistics on women in U. S. academic medicine, as prepared by the Association of American Medical Colleges (AAMC) in 1994. Recent trends of women medical school applicants, enrollees and graduates were presented. The distribution of women residents and women faculty members by department was also shown. Growth in the number of full professors, tenure status, and ethnicity of women were also compared with men. Three women medical school deans were reported. A discussion concerning the future trend of Japanese medical societies was included.
3.Activities to Learn The Importance of Advance Care Planning from The Perspective of Emergency Medicine
Nobuyuki UCHIDA ; Yoko SHIMAMURA ; Akiko NAKAMURA ; Tetsuya HOSHINO ; Toru MARUHASHI ; Toshihiro NAKAJIMA ; Keiichi YAMADA ; Shouichi SAITOU ; Akira SUNOHARA
An Official Journal of the Japan Primary Care Association 2020;43(2):70-72
4.Gingyo Gedokusan vs Oseltamivir for the Treatment of Uncomplicated Influenza and Influenza-like illness : An Open-label Prospective Study
Kentaro Iwata ; Wataru Igarashi ; Midori Honjo ; Takashi Nishimoto ; Kyoko Shinya ; Akiko Makino ; Kazuo Mitani ; Yoshiko Tatsumi ; Hiroyuki Ninomiya ; Kumi Higasa ; Seiichiro Usuki ; Hiroki Kagawa ; Daisuke Uchida ; Kohei Takimoto ; Rei Suganaga ; Hiroo Matsuo ; Yuichiro Oba ; Mami Horigome ; Hideaki Oka ; Goh Ohji ; Yasuhisa Abe ; Hiroyuki Yoshida ; Shohiro Kinoshita ; Midori Hirai
General Medicine 2013;14(1):13-22
Background: Gingyo-gedoku-san (GGGS) is an herbal medicine approved for upper respiratory infections in Japan. We conducted an open-label, multi-center, prospective trial, comparing GGGS with oseltamivir in patients with influenza and influenza-like illness (ILI) as a pilot study.
Methods: Subjects were healthy persons aged between 16 and 40, and were enrolled from January 12, 2010 to March 24, 2011. Fifteen patients were enrolled in this trial (8 and 7 for GGGS and oseltamivir, respectively). RT-PCR was positive for pandemic influenza A (H1N1) in 10 patients. The patients were provided with either GGGS or oseltamivir for 5 days. The primary outcome was mortality and/or hospitalization 7 days after the initial diagnosis. Body temperature and other clinical characteristics were also evaluated.
Results: All patients recovered from illness without complication or hospitalization. The mean time to resolve symptoms for the GGGS and oseltamivir groups was 3.9 days and 3.3 days, respectively (p=0.43). The GGGS group appeared to have a smaller symptom score AUC than the oseltamivir group, (p=0.26). Time to recover activity level appeared to be shorter in the GGGS group (p=0.10), with shorter time to recover health status (p=0.02). Sub-group analysis on patients with positive PCR showed similar results between the two groups.
Conclusion: GGGS was associated with symptom improvements resembling oseltamivir for both influenza and ILI. Randomized controlled trials involving larger sample sizes are needed to confirm these results.
Result Analysis
Print
Save
E-mail